Hybrid AF™ Therapy with the EPi-Sense® ST device brings a unified epi-endo approach to treating advanced Afib, supporting long-term rhythm control.
Discover the EPi-Sense ST device: https://okt.to/SDrdKy#Epeeps#HybridAFTherapy#Afib
New-onset Afib is the most common complication after cardiac surgery. The BoxX-NoAF Clinical Trial is exploring if post-op Afib can be reduced.
This innovative trial will set out to evaluate if cardiac ablation and LAA exclusion during cardiac surgery is effective in the reduction of new-onset Afib in cardiac surgery patients with risk factors, but no history of Afib.
With high rates of post-surgical pain, the cryoXT™ probe provides a non-opioid pain management option that manages symptoms at the time of the procedure.
Discover the latest advancement here: https://okt.to/ci9DM4#PainManagement#Amputation#VascSurg
Don’t miss an upcoming presentation at the International Coronary Congress Meeting, November 20-22.
Join Dr. Gianluca Torregrossa as he discusses outcomes from the TRAC-AF registry.
Program details: https://okt.to/uynsGY
Diabetes can affect more than blood sugar. Over time, it can damage nerves and reduce circulation, increasing the risk of foot wounds, infections and lower limb amputation.
Awareness, early detection and proactive foot care can help reduce the risk of serious complications. Learn the warning signs and talk with your healthcare provider about protecting your health. #DiabetesAwareness
Atrial fibrillation (Afib) doesn't look the same for everyone.
For some people, Afib can progress over time and become more difficult to treat. Hybrid AF™ Therapy combines a dual approach to treat Afib lasting longer than a year.
Explore Hybrid AF Therapy to learn more: https://okt.to/rSaVAP
#HybridAFTherapy#Afib#AdvancedAfib
What does Veterans Day mean to those who have served?
AtriCure Public Relations Specialist, Ben S, shares his perspective and reflects on the meaning of this day.
Today and every day, we honor and thank the veterans who have served our country.
#VeteransDay
Our Heart of AtriCure recipients demonstrate a commitment to quality, exemplify our patient-first focus, and embody our values at the heart of everything they do. Thank you and congratulations to Jenna, Sahar, Heidi, Jessica and Naga.
#HeartofAtriCure
Hybrid AF™ Therapy with the EPi-Sense® ST device brings a unified epi-endo approach to treating advanced Afib, supporting long-term rhythm control.
Discover the EPi-Sense ST device: https://t.co/34fbUdoXhd#Epeeps#HybridAFTherapy#Afib
This innovative trial will set out to evaluate if cardiac ablation and LAAE during cardiac surgery is effective in the reduction of new-onset Afib in cardiac surgery patients with risk factors, but no history of Afib.
With high rates of post-surgical pain, the cryoXT™ probe provides a non-opioid pain management option that manages symptoms at the time of the procedure.
Discover the latest advancement here: https://t.co/UbUGsiYdJE#PainManagement#Amputation#VascSurg
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.
Click "Agree" to confirm you are a Patient or a Caregiver.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
Stroke Awareness
Duration: 00:40
Addressing Afib Early
Duration: 1:11
BoxX-NoAF Trial
Duration: 00:24
Afib Goes Undertreated and Underdiagnosed in CABG Patients
Duration: 00:8
social media channels to keep updated on the latest at AtriCure.